Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triheptanoin for the treatment of glucose transport 1 deficiency

Triheptanoin for the treatment of glucose transport 1 deficiency

US Patent 10111848 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases2021
Anaplerotic therapy of huntington disease and other polyglutamine diseases2019
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Anaplerotic therapy of huntington disease and other polyglutamine diseases2017
Triheptanoin for the treatment of glucose transport 1 deficiency2016
Triheptanoin for the treatment of glucose transport 1 deficiency2016
Establishment of patient- or person-specific cardiac myocyte cell lines from hum2015
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015
Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease2013